Dei-Asamoa, Richard
Blocker, Riddick IV
Ercis, Mete
Frye, Mark A.
Ozerdem, Aysegul
Fiagbe, Delali
Veldic, Marin
Article History
Received: 27 November 2024
Revised: 30 September 2025
Accepted: 3 October 2025
First Online: 22 October 2025
Declarations
:
: N/A.
: N/A.
: N/A.
: Dr Mark A. Frye has received grant support from Assurex Health, Mayo Foundation and Breakthrough Discoveries for thriving with Bipolar Disorder (BD2), received CME travel and honoraria from Carnot Laboratories and American Physician Institute, and has Financial Interest/Stock ownership/Royalties from Chymia LLC.All other authors declare no competing interests.